COVID-19 and anaesthesia: Letter from NHS England and NHS Improvement

Blake Dark, Commercial Medicines Director of NHS England and NHS Improvement, has written to companies with guidance on anaesthesia and intensive care medicine. The letter reads:

In order to manage additional demand for anaesthesia and intensive care medicines, the Royal College of Anaesthetists and its partners, working with NHS England and NHS Improvement, have today published the following important guidance:

  • Anaesthesia: Guidance on potential changes to anaesthetic drug usage and administration during pandemic emergency pressures.
  • Intensive Care Medicine: Guidance on adaptations to standard UK critical care medication prescribing and administration practices during pandemic emergency pressures.
  • Frequently asked questions for patients.

During the COVID-19 pandemic, across many medical specialties, there is a need to adapt clinical practice to respond to the situation and ensure patient care guidelines are consistent, equitable, safe and appropriate.

Further coronavirus guidance for clinicians and NHS managers is available on the NHS England and NHS Improvement website

Many thanks


Tagged with

Published on 3. April 2020 in News, News UK